SOW
AKBA icon

State of Wyoming’s Akebia Therapeutics AKBA Stock Holding History

State of Wyoming’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,226
Closed -$8.41K – 1791
2025
Q4 		$8.41K Buy
+5,226
New +$10.9K ﹤0.01% 1738
2025
Q2 		– Sell
-59,206
Closed -$114K – 1850
2025
Q1 		$114K Buy
+59,206
New +$121K 0.02% 1111
2024
Q4 		– Sell
-48,016
Closed -$63.4K – 1603
2024
Q3 		$63.4K Sell
48,016
-1,711
-3% -$2.29K 0.01% 1335
2024
Q2 		$50.7K Buy
+49,727
New +$61.5K 0.01% 1318
2024
Q1 		– Sell
-39,725
Closed -$49.3K – 1607
2023
Q4 		$49.3K Sell
39,725
-34,285
-46% -$35K 0.01% 1308
2023
Q3 		$84.4K Buy
74,010
+25,803
+54% +$33.1K 0.02% 979
2023
Q2 		$44.1K Buy
+48,207
New +$46.5K 0.01% 1187

Other funds holding AKBA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State of Wyoming's AKBA Position: Q1 2026 in Review

State of Wyoming sold out of Akebia Therapeutics (AKBA) in Q1 2026, closing a stake of 5,226 shares — an estimated $8.41K sold.

State of Wyoming first reported a position in AKBA in Q2 2023 and held it in 7 quarters. The position peaked at $114K in Q1 2025. 171 funds tracked by Wall St. Rank hold AKBA as of Q1 2026.

  • State of Wyoming reported no remaining Akebia Therapeutics position as of Q1 2026 after selling out during the quarter.
  • State of Wyoming sold 5,226 Akebia Therapeutics shares in Q1 2026, an estimated $8.41K.
  • State of Wyoming first reported a position in Akebia Therapeutics in Q2 2023 and held it in 7 quarters.
  • State of Wyoming's Akebia Therapeutics position peaked at $114K in Q1 2025.
  • 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.